Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
22 July 2020 | Story Andre Damons | Photo Supplied
Dr Champion N Nyoni.

As yet another testament to the great work being done, as well as the dedication, passion, and hard work of staff members in the School of Nursing at the University of the Free State (UFS), a senior lecturer became the first UFS staff member to win the prestigious Sigma Emerging Nurse Researcher/Scholar award – making him only the third African to win this award. 

“I was overwhelmed to be honoured with this award as the third African to have won it in the history of the awards. To me, this is an indication that the quality of our work in the School of Nursing is top-notch and meets international standards, and that our contribution to nursing science and nursing education is outstanding,” says a proud Dr Champion N. Nyoni on his latest achievement. 

Sigma Theta Tau International (Sigma) is a global honour society for nurses that recognises and advances nursing through research and scholarship. Membership for this society includes a minimum of a master’s qualification and nomination from current members based on your contribution and the potential thereof for nursing at a national and global scale. 

The Emerging Nurse Researcher/Scholar Award, with the purpose of recognising nurses whose research and scholarship has impacted the profession and the people it serves, was introduced in 2015.

No easy process 
It is quite a rigorous process to become eligible for the award, explains Dr Nyoni. “One is nominated by peers who are also part of Sigma; these peers must motivate their nomination by providing evidence related to the research and scholarship of the nominee.” 

“In addition to the numerous reference reports from colleagues in the discipline of nursing, additional referrals are sought from colleagues in other professions (in the health sciences) who have worked and engaged with the research of the nominee. This application process is then evaluated for consideration, among others, by a global panel. I never thought that I would win this award, given the nature of the nomination process, and the heavy funding that other nurse researchers globally receive in comparison to Africa,” says Dr Nyoni.

According to a passionate Dr Nyoni, the award will also give him the energy to continue an academic track, especially in nursing and nursing education, with a focus on improving the quality of nursing education, the quality of nursing graduates, impacting the nursing workforce and thereby influencing the quality of health indicators, especially in Africa, where health systems are nurse-driven. 

Dr Nyoni is appreciative of the nurturing environment and brilliant colleagues in the School of Nursing, who are supporting his research career.

Quality nursing education

"We need quality nurses for quality nursing care, and this should be done through quality nursing education. I hope to use this award as part of a motivation strategy for young nurses to be engaged in scholarship and in academia, as there is a great need, especially in sub-Saharan Africa,” concludes Dr Nyoni.

When he was nominated, Dr Nyoni had close to 15 publications in nursing education and close to 40 presentations at local and international conferences. He also had several awards for his research work, including the Best Education Paper: Senior Category at the Faculty of Health Science’s Research Forum in 2019. 

Dr Nyoni is currently a postdoctoral fellow (the first) in the UFS School of Nursing and serves as chairperson on several boards of directors relating to health professions education in the African region, namely AfrIPEN and SAFRI. He is also supervising several master’s and PhD students.
 
• This award will be presented on Thursday at the International Nursing Research Congress that is now taking place online due to COVID-19.

News Archive

Inaugural lecture: Prof Robert Bragg, Dept. of Microbial, Biochemical and Food Biotechnology
2006-05-17



Attending the inaugural lecture were in front from the left Prof Robert Bragg (lecturer at the Department of Microbial, Biochemical and Food Biotechnology) and Frederick Fourie (Rector and Vice-Chancellor).  At the back from the left were Prof James du Preez (Departmental Chairperson:  Department of Microbial, Biochemical and Food Biotechnology) and Prof Herman van Schalkwyk (Dean: Faculty of Natural and Agricultural Sciences). Photo: Stephen Collett
 

A summary of an inaugural lecture delivered by Prof Robert Bragg at the University of the Free State:

CONTROL OF INFECTIOUS AVIAN DISEASES – LESSONS FOR MAN?

Prof Robert R Bragg
Department of Microbial, Biochemical and Food Biotechnology
University of the Free State

“Many of the lessons learnt in disease control in poultry will have application on human medicine,” said Prof Robert Bragg, lecturer at the University of the Free State’s (UFS) Department of Microbial, Biochemical and Food Biotechnology during his inaugural lecture.

Prof Bragg said the development of vaccines remains the main stay of disease control in humans as well as in avian species.  Disease control can not rely on vaccination alone and other disease-control options must be examined.  

“With the increasing problems of antibiotic resistance, the use of disinfection and bio security are becoming more important,” he said.

“Avian influenza (AI) is an example of a disease which can spread from birds to humans.  Hopefully this virus will not develop human to human transmission,” said Prof Bragg.

According to Prof Bragg, South Africa is not on the migration route of water birds, which are the main transmitters of AI.  “This makes South Africa one of the countries less likely to get the disease,” he said.

If the AI virus does develop human to human transmission, it could make the 1918 flu pandemic pale into insignificance.  During the 1918 flu pandemic, the virus had a mortality rate of only 3%, yet more than 50 million people died.

Although the AI virus has not developed human-to-human transmission, all human cases have been related to direct contact with infected birds. The mortality rate in humans who have contracted this virus is 67%.

“Apart from the obvious fears for the human population, this virus is a very serious poultry pathogen and can cause 100% mortality in poultry populations.  Poultry meat and egg production is the staple protein source in most countries around the world. The virus is currently devastating the poultry industry world-wide,” said Prof Bragg.

Prof Bragg’s research activities on avian diseases started off with the investigation of diseases in poultry.  “The average life cycle of a broiler chicken is 42 days.  After this short time, they are slaughtered.  As a result of the short generation time in poultry, one can observe changes in microbial populations as a result of the use of vaccines, antibiotics and disinfectants,” said Prof Bragg.   

“Much of my research effort has been directed towards the control of infectious coryza in layers, which is caused by the bacterium Avibacterium paragallinarum.  This disease is a type of sinusitis in the layer chickens and can cause a drop in egg product of up to 40%,” said Prof Bragg.

The vaccines used around the world in an attempt to control this disease are all inactivated vaccines. One of the most important points is the selection of the correct strains of the bacterium to use in the vaccine.

Prof Bragg established that in South Africa, there are four different serovars of the bacterium and one of these, the serovar C-3 strain, was believed to be unique to Southern Africa. He also recently discovered this serovar for the first time in Israel, thus indicating that this serovar might have a wider distribution than originally believed.

Vaccines used in this country did not contain this serovar.  Prof Bragg established that the long term use of vaccines not containing the local South African strain resulted in a shift in the population distribution of the pathogen.

Prof Bragg’s research activities also include disease control in parrots and pigeons.   “One of the main research projects in my group is on the disease in parrots caused by the circovirus Beak and Feather Disease virus. This virus causes serious problems in the parrot breeding industry in this country. This virus is also threatening the highly endangered and endemic Cape Parrot,” said Prof Bragg.

Prof Bragg’s research group is currently working on the development of a DNA vaccine which will assist in the control of the disease, not only in the parrot breeding industry, but also to help the highly endangered Cape Parrot in its battle for survival.

“Not all of our research efforts are directed towards infectious coryza or the Beak and Feather Disease virus.  One of my Masters students is currently investigating the cell receptors involved in the binding of Newcastle Disease virus to cancerous cells and normal cells of humans. This work will also eventually lead to a possible treatment of cancer in humans and will assist with the development of a recombinant vaccine for Newcastle disease virus,” said Prof Bragg.

We are also currently investigating an “unknown” virus which causes disease problems in poultry in the Western Cape,” said Prof Bragg.
 
“Although disinfection has been extensively used in the poultry industry, it has only been done at the pre-placement stage. In other words, disinfectants are used before the birds are placed into the house. Once the birds are placed, all use of disinfectants stops,” said Prof Bragg.

“Disinfection and bio security can be seen as the ‘Cinderella’ of disease control in poultry.  This is also true for human medicine. One just has to look at the high numbers of people who die from hospital-acquired infections to realise that disinfection is not a concept which is really clear in human health care,” said Prof Bragg.

Much research has been done in the control of diseases through vaccination and through the use of antibiotics. “These pillars of disease control are, however, starting to crumble and more effort is needed on disinfection and bio security,” said Prof Bragg.

Prof Bragg has been working in close co-operation with a chemical manufacturing company in Stellenbosch to develop a unique disinfectant which his highly effective yet not toxic to the birds.

As a result of this unique product, he has developed the continual disinfection program for use in poultry. In this program the disinfectant is used throughout the production cycle of the birds. It is also used to ensure that there is excellent pre-placement disinfection.

“The program is extensively used for the control of infectious diseases in the parrot-breeding industry in South Africa and the product has been registered in 15 countries around the world with registration in the USA in the final process,” said Prof Bragg.

“Although the problem of plasmid mediated resistance to disinfectants is starting to rear its ugly head, this has allowed for the opening of a new research field which my group will hopefully exploit in the near future,” he said.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept